{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:46:43Z","timestamp":1792061203366,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.7759\/cureus.117956","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:06:45Z","timestamp":1792058805000},"source":"Crossref","is-referenced-by-count":0,"title":["Glomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy"],"prefix":"10.7759","author":[{"given":"Tomoaki","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kajio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt RJ","year":"2013","unstructured":"Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013, 368:2402-14. 10.1056\/NEJMra1206793","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27689","article-title":"Predicting progression in IgA nephropathy","volume":"38","author":"Bartosik LP","year":"2001","unstructured":"Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001, 38:728-35. 10.1053\/ajkd.2001.27689","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran DC","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, et al.. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009, 76:534-45. 10.1038\/ki.2009.243","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard N","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J. Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol. 2015, 26:1503-12. 10.1681\/ASN.2014101000","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.05.018","article-title":"Properdin: a multifaceted molecule involved in inflammation and diseases","volume":"102","author":"Chen JY","year":"2018","unstructured":"Chen JY, Cortes C, Ferreira VP. Properdin: a multifaceted molecule involved in inflammation and diseases. Mol Immunol. 2018, 102:58-72. 10.1016\/j.molimm.2018.05.018","journal-title":"Mol Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.120","article-title":"IgM exacerbates glomerular disease progression in complement-induced glomerulopathy","volume":"88","author":"Panzer SE","year":"2015","unstructured":"Panzer SE, Laskowski J, Renner B, et al.. IgM exacerbates glomerular disease progression in complement-induced glomerulopathy. Kidney Int. 2015, 88:528-37. 10.1038\/ki.2015.120","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an\u00a0update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi H","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al.. Oxford classification of IgA nephropathy 2016: an\u00a0update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017, 91:1014-21. 10.1016\/j.kint.2017.02.003","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27690","article-title":"Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy","volume":"38","author":"Hotta O","year":"2001","unstructured":"Hotta O, Miyazaki M, Furuta T, et al.. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001, 38:736-43. 10.1053\/ajkd.2001.27690","journal-title":"Am J Kidney Dis"},{"key":"ref9","article-title":"Pathophysiology of IgA Nephropathy and Tonsillectomy With Steroid Pulse Therapy (Book in Japanese)","author":"Hotta O","year":"2008","unstructured":"Hotta O. Pathophysiology of IgA Nephropathy and Tonsillectomy With Steroid Pulse Therapy (Book in Japanese). Medikaru Saiensu int\u0101nashonaru, Tokyo, Japan; 2008."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178018","article-title":"A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy","volume":"12","author":"Miyawaki Y","year":"2017","unstructured":"Miyawaki Y, Katsuyama T, Sada KE, et al.. A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy. PLoS One. 2017, 12:e0178018. 10.1371\/journal.pone.0178018","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-012-0752-x","article-title":"Acute kidney injury associated with nafronyl oxalate overdose","volume":"17","author":"Kim MJ","year":"2013","unstructured":"Kim MJ, Lee JS, Kim SW. Acute kidney injury associated with nafronyl oxalate overdose. Clin Exp Nephrol. 2013, 17:437-8. 10.1007\/s10157-012-0752-x","journal-title":"Clin Exp Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1657-0","article-title":"A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity","volume":"23","author":"Okonogi H","year":"2019","unstructured":"Okonogi H, Kawamura T, Joh K, et al.. A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity. Clin Exp Nephrol. 2019, 23:16-25. 10.1007\/s10157-018-1657-0","journal-title":"Clin Exp Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki H","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, et al.. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011, 22:1795-803. 10.1681\/ASN.2011050464","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014070697","article-title":"Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study","volume":"26","author":"Tesar V","year":"2015","unstructured":"Tesar V, Troyanov S, Bellur S, et al.. Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study. J Am Soc Nephrol. 2015, 26:2248-58. 10.1681\/ASN.2014070697","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040433","article-title":"A multicenter study of the predictive value of crescents in IgA nephropathy","volume":"28","author":"Haas M","year":"2017","unstructured":"Haas M, Verhave JC, Liu ZH, et al.. A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol. 2017, 28:691-701. 10.1681\/ASN.2016040433","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.027","article-title":"Results of a randomized double-blind placebo-controlled phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy","volume":"105","author":"Zhang H","year":"2024","unstructured":"Zhang H, Rizk DV, Perkovic V, et al.. Results of a randomized double-blind placebo-controlled phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy. Kidney Int. 2024, 105:189-99. 10.1016\/j.kint.2023.09.027","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040947","article-title":"An update on current therapeutic options in IgA nephropathy","volume":"13","author":"Lim RS","year":"2024","unstructured":"Lim RS, Yeo SC, Barratt J, Rizk DV. An update on current therapeutic options in IgA nephropathy. J Clin Med. 2024, 13:947. 10.3390\/jcm13040947","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/537671-glomerular-properdin-deposition-suggests-a-favorable-therapeutic-response-to-tonsillectomy-and-steroid-pulse-therapy-in-iga-nephropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:06:46Z","timestamp":1792058806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/537671-glomerular-properdin-deposition-suggests-a-favorable-therapeutic-response-to-tonsillectomy-and-steroid-pulse-therapy-in-iga-nephropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.117956","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}